Anaphylaxis: Recognition, Emergency Management, and Long-Term Prevention

Anaphylaxis is a severe, systemic, IgE-mediated (or non-IgE) hypersensitivity reaction that is rapid in onset and may cause death. Prompt recognition and intramuscular epinephrine are lifesaving.

Diagnostic Criteria (WAO/NSAID)

Anaphylaxis is highly likely when any ONE of three criteria is met:

  1. Acute onset (minutes–hours) with skin/mucosal involvement (hives, angioedema, flush) AND respiratory compromise (dyspnea, wheeze, stridor, hypoxia) OR reduced BP/end-organ dysfunction.
  2. Two or more of: skin/mucosal, respiratory, cardiovascular (hypotension, syncope), GI (cramp, vomiting) after likely allergen exposure.
  3. Reduced BP after known allergen exposure (systolic <90 mmHg or >30% drop from baseline).

Common Triggers

  • Foods: peanut, tree nuts, shellfish, fish, milk, egg, wheat, soy, sesame (9th major allergen US 2023).
  • Venom: Hymenoptera (bee, wasp, hornet, yellow jacket, fire ant).
  • Medications: β-lactams, NSAIDs, biologics, NMBAs, radiocontrast.
  • Latex, exercise (food-dependent exercise-induced anaphylaxis), idiopathic.

Emergency Treatment Algorithm

  1. Recognize → Call 911 → Epinephrine IM (anterolateral mid-thigh) 1:1000
    • Adults: 0.3–0.5 mg (0.3–0.5 mL)
    • Children: 0.01 mg/kg (max 0.3 mg); 0.15 mg auto-injector for 7.5–25 kg; 0.3 mg for >25 kg
  2. Supine position + leg elevation (if tolerated); left lateral if vomiting/pregnant.
  3. High-flow O₂; IV access; large-volume crystalloid bolus (20 mL/kg) if hypotensive.
  4. Adjuncts (AFTER epinephrine): H1 antihistamine (diphenhydramine 25–50 mg IV/IM), H2 blocker (famotidine 20 mg IV), corticosteroid (methylprednisolone 1–2 mg/kg IV) — for biphasic risk reduction, not acute reversal.
  5. Refractory: Epinephrine infusion (0.1–1 mcg/kg/min), vasopressors (norepinephrine), glucagon if on β-blocker.
  6. Observe 4–6+ hours (biphasic: 1–20%, peaks 8–12h); admit if severe, delayed presentation, poor access to care.

Long-Term Prevention

  • Confirm Trigger: Allergist evaluation — history, skin prick/sIgE, component testing, oral challenge.
  • Strict Avoidance: Label reading, cross-contact prevention, restaurant communication.
  • Two EAIs at All Times: Replace before expiry; store 15–30°C.
  • Written Anaphylaxis Action Plan: Share with school, work, caregivers.
  • Medical ID: Bracelet/necklace/digital.
  • Venom Immunotherapy: 95–98% protection for Hymenoptera allergy.
  • Food OIT / Epicutaneous Immunotherapy: Emerging options for peanut, milk, egg (specialized centers).
  • Alpha-gal Syndrome: Tick bite prevention; mammalian meat avoidance.

Special Populations

  • Infants/Children: Weight-based dosing; AUVI-Q 0.1 mg for 7.5–15 kg.
  • Pregnancy: Epinephrine safe; anaphylaxis risks fetal hypoxia.
  • β-Blocker/ACEi Users: Refractory hypotension; glucagon 1–5 mg IV for β-blockade; avoid ACEi if history of angioedema.

Epinephrine FIRST, epinephrine FAST. No contraindication to epinephrine in anaphylaxis. Delay increases fatality risk.

Bulimia - Related Articles